KOGI CORPORATION Logo

KOGI CORPORATION

Engineering AI & IoT zero-touch hover interfaces for public kiosks and terminals.

5603 | T

Overview

Corporate Details

ISIN(s):
JP3286400001
LEI:
Country:
Japan
Address:
姫路市大津区勘兵衛町4丁目1
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

KOGI Corporation is an applied AI and IoT engineering company specializing in 'contact-free optimization solutions'. The company develops innovative technologies, such as zero-touch hover interfaces for public kiosks and terminals, designed to enhance user interaction and operational efficiency for businesses. Serving clients in both the public and private sectors, with noted experience in healthcare and retail, KOGI operates through a global network of channel partners. This network provides local promotion, delivery, and support services across numerous countries in the Americas, Europe, the Middle East, Africa, and Asia.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-12 04:50
Registration Form
確認書
Japanese 8.1 KB
2025-11-12 04:49
Interim Report
半期報告書-第121期(2025/04/01-2026/03/31)
Japanese 189.8 KB
2025-06-27 06:13
Post-Annual General Meeting Information
臨時報告書
Japanese 26.1 KB
2025-06-25 02:32
Governance Information
内部統制報告書-第120期(2024/04/01-2025/03/31)
Japanese 24.3 KB
2025-06-25 02:31
Registration Form
確認書
Japanese 8.0 KB
2025-06-25 02:30
Annual Report
有価証券報告書-第120期(2024/04/01-2025/03/31)
Japanese 1.0 MB
2024-11-11 05:18
Interim Report
半期報告書-第120期(2024/04/01-2025/03/31)
Japanese 196.7 KB
2024-11-11 05:18
Report Publication Announcement
確認書
Japanese 8.0 KB
2024-06-27 09:27
Post-Annual General Meeting Information
臨時報告書
Japanese 23.1 KB
2024-06-26 05:54
Governance Information
内部統制報告書-第119期(2023/04/01-2024/03/31)
Japanese 22.1 KB
2024-06-26 05:53
Registration Form
確認書
Japanese 8.0 KB
2024-06-26 05:52
Annual Report
有価証券報告書-第119期(2023/04/01-2024/03/31)
Japanese 1020.5 KB
2024-02-09 01:55
Regulatory News Service
確認書
Japanese 8.0 KB
2024-02-09 01:54
Quarterly Report
四半期報告書-第119期第3四半期(2023/10/01-2023/12/31)
Japanese 168.2 KB
2023-11-10 01:12
Report Publication Announcement
確認書
Japanese 8.0 KB

Automate Your Workflow. Get a real-time feed of all KOGI CORPORATION filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KOGI CORPORATION

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KOGI CORPORATION via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

VALIRX PLC Logo
Advancing oncology & women's health therapeutics and offering preclinical research services.
United Kingdom
VAL
VALUE GOLF Inc. Logo
A golf services hub offering reservations, solo player bookings, e-commerce, lessons, and tours.
Japan
3931
Value HR Co., Ltd. Logo
Offers a health management platform and consulting for corporate health insurance societies in Japan.
Japan
6078
Global OTA for curated tours & experiences, focusing on travel to and from Japan.
Japan
7048
A South Korean travel company offering global tour packages, flights, hotels, and corporate travel.
South Korea
094850
Virax Biolabs Group Ltd Logo
Specializes in T-cell immunity tests and diagnostics for profiling viral disease responses.
United States of America
VRAX
VisionSys AI Inc Logo
Develops AI-powered brain-computer interfaces for the healthcare and biotech sectors.
United States of America
VSA
Vivesto Logo
Develops and licenses novel cancer therapies for humans and animals using proprietary drug delivery.
Sweden
VIVE
Vor Biopharma Inc. Logo
Clinical-stage biotech developing next-gen medicines that target the root cause of autoimmune disease.
United States of America
VOR
Voronoi, Inc. Logo
Develops selective kinase inhibitors and targeted protein degraders for precision oncology.
South Korea
310210

Talk to a Data Expert

Have a question? We'll get back to you promptly.